Cantex Pharmaceuticals' Series C Round

Cantex Pharmaceuticals raised a round of funding on August 11, 2010.

Cantex, formerly Paringenix, is a clinical stage biopharmaceutical company focused on developing and commercializing proprietary compounds that enhance the efficacy and safety of the treatment of canc…

Articles about Cantex Pharmaceuticals' Series C Round: